During the past decade, SOS Ematologia Ospedale C. Massaia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SOS Ematologia Ospedale C. Massaia" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "SOS Ematologia Ospedale C. Massaia" are "Follicular Lymphoma" (2 trials) and "Waldenstrom Macroglobulinemia" (1 trials). Many other conditions were trialed in "SOS Ematologia Ospedale C. Massaia" in a lesser frequency.

Most popular intervention types in "SOS Ematologia Ospedale C. Massaia" are "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "MRD and clonal evolution" (1 trials), "Metabolic activity measured by FDG-PET" (1 trials) and "Rituximab, Mitoxantrone, Bendamustine" (1 trials). Other intervention names were less common.

The vast majority of trials in "SOS Ematologia Ospedale C. Massaia" are 3 trials for "All" genders.

Currently, there are NaN active trials in "SOS Ematologia Ospedale C. Massaia". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in SOS Ematologia Ospedale C. Massaia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SOS Ematologia Ospedale C. Massaia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".